NCT02115958View on ClinicalTrials.gov

The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Neoplasms, Lung
Interventions
BIOLOGICAL

cancer stem cell vaccine

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02115958 - The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine | Biotech Hunter | Biotech Hunter